Braidwell-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
64
Total Value
2844802567
Accession Number
0001420506-25-001293
Form Type
13F-HR
Manager Name
Braidwell-Lp
Data Enrichment
75% identified
48 identified16 unidentified

Holdings

64 positions • $2.8B total value
Manager:
Search and click to pin securities to the top
Page 2 of 4
TransMedics Group, Inc.
Shares:854.9K
Value:$57.5M
% of Portfolio:2.0% ($57.5M/$2.8B)
Guardant Health, Inc.
Shares:1.3M
Value:$56.5M
% of Portfolio:2.0% ($56.5M/$2.8B)
Edgewise Therapeutics, Inc.
Shares:2.5M
Value:$54.1M
% of Portfolio:1.9% ($54.1M/$2.8B)
Inspire Medical Systems, Inc.
Shares:302.4K
Value:$48.2M
% of Portfolio:1.7% ($48.2M/$2.8B)
10806XAD4
Shares:
Value:$43.8M
% of Portfolio:1.5% ($43.8M/$2.8B)
45258DAB1
Shares:
Value:$43.8M
% of Portfolio:1.5% ($43.8M/$2.8B)
Kiniksa Pharmaceuticals International, plc
Shares:2.0M
Value:$43.6M
% of Portfolio:1.5% ($43.6M/$2.8B)
INTUITIVE SURGICAL INC
Shares:88.0K
Value:$43.6M
% of Portfolio:1.5% ($43.6M/$2.8B)
Alphatec Holdings, Inc.
Shares:4.3M
Value:$43.2M
% of Portfolio:1.5% ($43.2M/$2.8B)
Spyre Therapeutics, Inc.
Shares:2.6M
Value:$41.6M
% of Portfolio:1.5% ($41.6M/$2.8B)
Blueprint Medicines Corp
Shares:440.0K
Value:$38.9M
% of Portfolio:1.4% ($38.9M/$2.8B)
Dyne Therapeutics, Inc.
Shares:3.6M
Value:$37.9M
% of Portfolio:1.3% ($37.9M/$2.8B)
Apellis Pharmaceuticals, Inc.
Shares:1.7M
Value:$36.1M
% of Portfolio:1.3% ($36.1M/$2.8B)
Adaptive Biotechnologies Corp
Shares:4.8M
Value:$35.7M
% of Portfolio:1.3% ($35.7M/$2.8B)
Viking Therapeutics, Inc.
Shares:1.4M
Value:$34.7M
% of Portfolio:1.2% ($34.7M/$2.8B)
Penumbra Inc
Shares:110.1K
Value:$29.4M
% of Portfolio:1.0% ($29.4M/$2.8B)
Bicara Therapeutics Inc.
Shares:2.2M
Value:$28.2M
% of Portfolio:1.0% ($28.2M/$2.8B)
Day One Biopharmaceuticals, Inc.
Shares:3.5M
Value:$28.0M
% of Portfolio:1.0% ($28.0M/$2.8B)
ORTHOPEDIATRICS CORP
Shares:1.1M
Value:$27.3M
% of Portfolio:1.0% ($27.3M/$2.8B)
HARROW, INC.
Shares:956.8K
Value:$25.5M
% of Portfolio:0.9% ($25.5M/$2.8B)